Illumina Completes Acquisition of Verinata Health

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced it has completed its previously announced acquisition of Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities. As of the close, Verinata Health became a wholly owned subsidiary of Illumina. "We look forward to working with the talented [...]

One rheometer, two EC motors, all possibilities: MCR 702 TwinDrive™

Anton Paar’s TwinDriveTM technology combines two powerful synchronous EC (Electrically Commutated) motor units in a modular setup: the upper EC motor in the rheometer is permanent; the lower EC motor can be extracted and integrated at will. Due to the EC motor's renowned dynamism and precision, users have several options of how to employ these [...]

Hologic Announces Launch of 6.25% Senior Notes Exchange Offer

BEDFORD, Mass., -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that it has commenced a registered exchange offer (the Exchange Offer) to exchange up to $1 billion aggregate [...]

Biosearch Technologies Announces Acquisition of European Companies DNA Technology and VitraBio

NOVATO, CA, – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated, custom-manufactured oligonucleotides and specialty amidites and CPGs to the research and diagnostics markets, announced today that it has acquired the oligonucleotide manufacturing division of the Danish company DNA Technology A/S (DNA Technology) and German CPG manufacturer VitraBio GmbH (VitraBio). With the acquisition of [...]

Highly Purified Chondroitinase ABC for Neural Regeneration Research

AMSBIO, a specialist supplier of high purity reagents for glycobiology and regenerative medicine, has announced the launch of a new, highly purified Chondroitinase ABC. This new enzyme is supplied protease-free, carrier-free and with low-endotoxin levels for use in neuroscience and regenerative medicine research. Chondroitin Sulfate Proteoglycans (CSPGs) are involved in the inhibition of axon regeneration [...]

NeuroInDx Unveils Kuiqpick™, Its New Cell and Tissue Acquisition System for Research Labs

LOS ANGELES -- NeuroInDx, Inc., a biotech company focused on the development of novel technologies for the biological sciences, today unveiled an innovative new cell and tissue acquisition instrument, Kuiqpick™, which is significantly less expensive and easier for researchers to use in the lab than existing laser-assisted microdissection systems. “We highly recommend the Kuiqpick for [...]

Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers

CARLSBAD, Calif.,-- Life Technologies Corporation (NASDAQ: LIFE) today announced that the new Center for Personalized Medicine (CPM) at Roswell Park Cancer Institute (RPCI) has purchased four Ion Proton™ sequencers and two Ion Personal Genome Machine™ (PGM™) sequencers. Founded in 1898, Roswell Park Cancer Institute was one of the first cancer centers in the country to [...]

Agilent Technologies Introduces HaloPlex Exome Kits and SureCall Software

Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of target-enrichment products with the introduction of HaloPlex exome kits and SureCall software. The new additions are designed to complement Agilent's Web-based SureDesign and custom HaloPlex gene panels to provide a complete, integrated workflow. "These products simplify the sequencing of clinical research samples," said Olle Ericsson, [...]

Danaher Announces Quarterly Dividend

WASHINGTON, D.C., -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on April 26, 2013 to holders of record on March 28, 2013.

N-of-One, Inc. Partners with Fox Chase Cancer Center to Provide Molecular Interpretation and Treatment Strategy Analysis for Patients Receiving CancerCode-45™ DNA Sequencing

WALTHAM, Mass.,— N-of-One, Inc., a leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, today announced a partnership with Fox Chase Cancer Center in Philadelphia, to provide molecular interpretation and treatment strategy analysis for genome sequencing and testing provided to advanced stage cancer patients through the Cancer Genome Institute at Fox Chase. [...]

Access IBO on Knowledge Center